The Journal of Immunology, Vol 149, Issue 8 2641-2649, Copyright © 1992 by American Association of Immunologists

ARTICLES

Identification and characterization of the murine homologue of CD22, a B lymphocyte-restricted adhesion molecule

RM Torres, CL Law, L Santos-Argumedo, PA Kirkham, K Grabstein, RM Parkhouse and EA Clark
Department of Microbiology, University of Washington, Seattle 98195.

The human B lymphocyte-specific Ag, CD22, is a cell adhesion molecule expressed on the surface during a narrow window of B cell development, coincident with surface IgD. A ligand for CD22 has recently been identified on human T cells as the low molecular mass isoform of the leukocyte common Ag, CD45RO. CD22 has been reported to function in the regulation of both T and B cell activation in vitro. In this study, we report the isolation and expression of a molecular cDNA clone encoding the murine homologue of CD22, mCD22. Within their predicted protein sequences, murine and human sequences overall have 62% identity, which includes 18 of 20 extracellular cysteines and six of six cytoplasmic tyrosines. BHK cells transfected with mCD22 cDNA specifically adhere to resting and activated T lymphocytes and in addition bound activated, but not resting, B cells. Five Th clones were analyzed for their ability to adhere to mCD22; two Th0 clones and one Th1 clone bound CD22+ BHK transfectants, but not all T cell clones bound CD22+ cells: another Th1 clone and a Th2 clone did not. mCD22+ BHK transfectants were also specifically bound by the B cell-specific mAb, NIM-R6, demonstrating that this mAb is specific for murine CD22. Human cell lines expressing the counter-receptors for human CD22 were also examined for adhesion to the murine CD22 homologue; the epitope responsible for B cell adhesion to CD22 is conserved, whereas the T cell epitope binding to CD22 is not. The cDNA and mAb to murine CD22 will be useful for defining the in vivo function of CD22.

This article has been cited by other articles:

				L. Nitschke, F. Lajaunias, T. Moll, L. Ho, E. Martinez-Soria, S. Kikuchi, M.-L. Santiago-Raber, C. Dix, R. M. E. Parkhouse, and S. Izui Expression of aberrant forms of CD22 on B lymphocytes in Cd22a lupus-prone mice affects ligand binding Int. Immunol., January 1, 2006; 18(1): 59 - 68. [Abstract] [Full Text] [PDF]

				J. G. Sathish, J. Walters, J. C. Luo, K. G. Johnson, F. G. LeRoy, P. Brennan, K. P. Kim, S. P. Gygi, B. G. Neel, and R. J. Matthews CD22 Is a Functional Ligand for SH2 Domain-containing Protein-tyrosine Phosphatase-1 in Primary T Cells J. Biol. Chem., November 12, 2004; 279(46): 47783 - 47791. [Abstract] [Full Text] [PDF]

				M. Zhang and A. Varki Cell surface sialic acids do not affect primary CD22 interactions with CD45 and surface IgM nor the rate of constitutive CD22 endocytosis Glycobiology, November 1, 2004; 14(11): 939 - 949. [Abstract] [Full Text] [PDF]

				Y. Du, J. Honeychurch, M. S. Cragg, M. Bayne, M. J. Glennie, P. W. M. Johnson, and T. M. Illidge Antibody-induced intracellular signaling works in combination with radiation to eradicate lymphoma in radioimmunotherapy Blood, February 15, 2004; 103(4): 1485 - 1494. [Abstract] [Full Text] [PDF]

				J. Honeychurch, M. J. Glennie, P. W. M. Johnson, and T. M. Illidge Anti-CD40 monoclonal antibody therapy in combination with irradiation results in a CD8 T-cell-dependent immunity to B-cell lymphoma Blood, August 15, 2003; 102(4): 1449 - 1457. [Abstract] [Full Text] [PDF]

				B. E. Collins, O. Blixt, N. V. Bovin, C.-P. Danzer, D. Chui, J. D. Marth, L. Nitschke, and J. C. Paulson Constitutively unmasked CD22 on B cells of ST6Gal I knockout mice: novel sialoside probe for murine CD22 Glycobiology, September 1, 2002; 12(9): 563 - 571. [Abstract] [Full Text] [PDF]

				F. Lajaunias, L. Nitschke, T. Moll, E. Martinez-Soria, I. Semac, Y. Chicheportiche, R. M. E. Parkhouse, and S. Izui Differentially Regulated Expression and Function of CD22 in Activated B-1 and B-2 Lymphocytes J. Immunol., June 15, 2002; 168(12): 6078 - 6083. [Abstract] [Full Text] [PDF]

				K. L. Otipoby, K. E. Draves, and E. A. Clark CD22 Regulates B Cell Receptor-mediated Signals via Two Domains That Independently Recruit Grb2 and SHP-1 J. Biol. Chem., November 16, 2001; 276(47): 44315 - 44322. [Abstract] [Full Text] [PDF]

				D. H. Kono, M. S. Park, A. Szydlik, K. M. Haraldsson, J. D. Kuan, D. L. Pearson, P. Hultman, and K. M. Pollard Resistance to Xenobiotic-Induced Autoimmunity Maps to Chromosome 1 J. Immunol., August 15, 2001; 167(4): 2396 - 2403. [Abstract] [Full Text] [PDF]

				J. Honeychurch, A. L. Tutt, T. Valerius, I. A. F. M. Heijnen, J. G. J. Van de Winkel, and M. J. Glennie Therapeutic efficacy of Fcgamma RI/CD64-directed bispecific antibodies in B-cell lymphoma Blood, November 15, 2000; 96(10): 3544 - 3552. [Abstract] [Full Text] [PDF]

				C. Mary, C. Laporte, D. Parzy, M.-L. Santiago, F. Stefani, F. Lajaunias, R. M. E. Parkhouse, T. L. O'Keefe, M. S. Neuberger, S. Izui, et al. Cd22a PRE-mRNA Dysregulated Expression of the Cd22 Gene as a Result of a Short Interspersed Nucleotide Element Insertion in Cd22a Lupus-Prone Mice J. Immunol., September 15, 2000; 165(6): 2987 - 2996. [Abstract] [Full Text] [PDF]

				T. M. Illidge, M. S. Cragg, H. M. McBride, R. R. French, and M. J. Glennie The Importance of Antibody-Specificity in Determining Successful Radioimmunotherapy of B-Cell Lymphoma Blood, July 1, 1999; 94(1): 233 - 243. [Abstract] [Full Text] [PDF]

				M. Huber, L. Izzi, P. Grondin, C. Houde, T. Kunath, A. Veillette, and N. Beauchemin The Carboxyl-terminal Region of Biliary Glycoprotein Controls Its Tyrosine Phosphorylation and Association with Protein-tyrosine Phosphatases SHP-1 and SHP-2 in Epithelial Cells J. Biol. Chem., January 1, 1999; 274(1): 335 - 344. [Abstract] [Full Text] [PDF]

				A. L. Tutt, R. R. French, T. M. Illidge, J. Honeychurch, H. M. McBride, C. A. Penfold, D. T. Fearon, R. M. E. Parkhouse, G. G. B. Klaus, and M. J. Glennie Monoclonal Antibody Therapy of B Cell Lymphoma: Signaling Activity on Tumor Cells Appears More Important Than Recruitment of Effectors J. Immunol., September 15, 1998; 161(6): 3176 - 3185. [Abstract] [Full Text] [PDF]

				L. Lai, N. Alaverdi, L. Maltais, and H. C. Morse III Mouse Cell Surface Antigens: Nomenclature and Immunophenotyping J. Immunol., April 15, 1998; 160(8): 3861 - 3868. [Abstract] [Full Text] [PDF]

				M. Vinson, P. A. van der Merwe, Sør. Kelm, A. May, E. Y. Jones, and P. R. Crocker Characterization of the Sialic Acid-binding Site in Sialoadhesin by Site-directed Mutagenesis J. Biol. Chem., April 19, 1996; 271(16): 9267 - 9272. [Abstract] [Full Text] [PDF]

				P. A. van der Merwe, P. R. Crocker, M. Vinson, A. N. Barclay, R. Schauer, and Sør. Kelm Localization of the Putative Sialic Acid-binding Site on the Immunoglobulin Superfamily Cell-surface Molecule CD22 J. Biol. Chem., April 19, 1996; 271(16): 9273 - 9280. [Abstract] [Full Text] [PDF]

				D. Nath, P. A. van der Merwe, Sør. Kelm, P. Bradfield, and P. R. Crocker The Amino-terminal Immunoglobulin-like Domain of Sialoadhesin Contains the Sialic Acid Binding Site J. Biol. Chem., November 3, 1995; 270(44): 26184 - 26191. [Abstract] [Full Text] [PDF]

				G. Doody, L. Justement, C. Delibrias, R. Matthews, J Lin, M. Thomas, and D. Fearon A role in B cell activation for CD22 and the protein tyrosine phosphatase SHP Science, July 14, 1995; 269(5221): 242 - 244. [Abstract] [PDF]

				L. D. Powell and A. Varki I-type Lectins J. Biol. Chem., June 16, 1995; 270(24): 14243 - 14246. [Full Text] [PDF]

				L. D. Powell, R. K. Jain, S. Sabesan, and A. Varki Characterization of Sialyloligosaccharide Binding by Recombinant Soluble and Native Cell-associated CD22 J. Biol. Chem., March 31, 1995; 270(13): 7523 - 7532. [Abstract] [Full Text] [PDF]